How autonomous diagnostics for DR gave a ‘jump-start’ to AI in ophthalmologyByLynda ChartersMarch 30th 2020
COVID-19: How eyecare professionals are taking precautions ByRishi P. Singh, MD, FASRSMarch 23rd 2020
IRIS Registry study: Overall anti-VEGF injection intervals for wet AMD similar at 1, 2 years of treatmentByMathew W. MacCumber, MD, PhDMarch 3rd 2020
Researchers identify biomarkers for selecting AMD patients for TES protocol ByMichelle Dalton, ELSJanuary 31st 2020
Research targets gene therapy for exudative AMD patientsByCheryl Guttman Krader, BS, PharmDecember 11th 2019
Is deep learning the future of diabetic retinopathy screening?ByMichelle Dalton, ELSDecember 11th 2019
Early intervention best for patients with diabetic eye diseasesByMichelle Dalton, ELSNovember 20th 2019
Ultra-widefield OCT ‘may be the only imaging’ needed to manage PDRByMichelle Dalton, ELSNovember 15th 2019
Anti-VEGF injections and glaucoma: Surgeons must watch IOP elevation ByLouise GagnonNovember 12th 2019